Publication:
Technical challenges for complete implementation of automated growth-based methods for microbiological examination of advanced therapy medicinal products. What's wrong with Candida albicans?

dc.contributor.authorRodríguez-Acosta, Antonio
dc.contributor.authorChaparro-García, Jesús
dc.contributor.authorDe-Toro, Inmaculada
dc.contributor.authorMaldonado-Sánchez, Rafael
dc.contributor.authorMuñoz-Fernández, Raquel
dc.contributor.authorAntúnez, Cristina
dc.contributor.authorFrecha, Cecilia
dc.contributor.authorLeyva, Laura
dc.date.accessioned2023-05-03T15:03:36Z
dc.date.available2023-05-03T15:03:36Z
dc.date.issued2022-01-13
dc.description.abstractAutomated growth-based methods for sterility testing of cell-therapy products should be qualified to demonstrate that they are equivalent to, or better than, the conventional reference method. The aim of the present study was to assess the ability of the BACTEC FX40 system to detect low microbial contamination and to confirm the suitability of the method in the presence of seven different human mesenchymal cell-based products, according to Ph. Eur. 2.6.27. Additionally, a study to select the best vial to detect fungus contamination was performed. Microorganisms representing Gram-negative, Gram-positive, aerobic, anaerobic, spore-forming, slow-growing bacteria, yeast and mold were prepared in either Dulbecco's PBS or seven biological matrices containing approximately 5, 10, and 15 colony-forming units (CFU) per sample. These preparations were inoculated to the specific media required for each test method: (i) BACTEC aerobic and anaerobic vials; (ii) aerobic and anaerobic media for direct inoculation; and (iii) Trypcase soy 3P or Brucella blood agar plates. Colonies from cultures were identified using MALDI-TOF mass spectrometry. The BACTEC FX40 system, in both Dulbecco's PBS and the biological matrices with a 5-CFU inoculum, detected most of the microorganisms significantly faster than the conventional method, despite the presence of a matrix containing gentamicin and several matrices containing 10% DMSO. Conversely, it showed an extremely delayed detection of Candida albicans compared with the conventional method. The addition of a Mycosis IC/F (MYC) vial decreased radically the time to detection (TTD) of C. albicans (28.2 ± 1.8 h) compared with the conventional method (36 h). When a MYC vial was added to the standard aerobic and anaerobic vials to test each sample, BACTEC FX40 was shown to be a superior alternative sterility method for cell-therapy products contaminated with low inocula, with a faster TTD for microbial growth compared with the conventional method (5 versus 14 days). The studies were carried out in different cell-based matrices with sensitivities and specificities of 100% for all the tested strains at 15-, 10- and 5-CFU inoculum, with the exception of Kocuria rhizophila at 5 CFU (90.48% sensitivity and 100% specificity).
dc.identifier.doi10.1016/j.jcyt.2021.11.002
dc.identifier.essn1477-2566
dc.identifier.pmid35033424
dc.identifier.unpaywallURLhttp://www.isct-cytotherapy.org/article/S1465324921008811/pdf
dc.identifier.urihttp://hdl.handle.net/10668/22298
dc.issue.number3
dc.journal.titleCytotherapy
dc.journal.titleabbreviationCytotherapy
dc.language.isoen
dc.organizationHospital Universitario Regional de Málaga
dc.organizationHospital Universitario Regional de Málaga
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.organizationC.T.S. Málaga
dc.page.number320-333
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectCandida albicans
dc.subjectautomated growth-based methods
dc.subjectblood culture system
dc.subjectcell therapy products
dc.subjectmethod suitability
dc.subjectsterility testing
dc.subject.meshCandida albicans
dc.subject.meshCell- and Tissue-Based Therapy
dc.subject.meshCulture Media
dc.subject.meshDrug Contamination
dc.subject.meshHumans
dc.subject.meshInfertility
dc.titleTechnical challenges for complete implementation of automated growth-based methods for microbiological examination of advanced therapy medicinal products. What's wrong with Candida albicans?
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number24
dspace.entity.typePublication

Files